Literature DB >> 16926262

GnRH agonist for luteal support in IVF? Setting the balance between enthusiasm and caution.

Cornelis B Lambalk1, Roy Homburg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926262     DOI: 10.1093/humrep/del321

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


× No keyword cloud information.
  5 in total

1.  Single-dose administration of a short-acting gonadotropin-releasing hormone agonist does not affect cycle outcome in frozen-thawed embryo transfer cycles.

Authors:  Hanbi Wang; Xian Tang; Orhan Bukulmez; Chengyan Deng; Qi Yu; Yuanzheng Zhou; Zhengyi Sun; Jingran Zhen; Xue Wang; Meizhi Liu
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

2.  Contribution to More Patient-Friendly ART Treatment: Efficacy of Continuous Low-Dose GnRH Agonist as the Only Luteal Support-Results of a Prospective, Randomized, Comparative Study.

Authors:  Céline Pirard; Ernest Loumaye; Pascale Laurent; Christine Wyns
Journal:  Int J Endocrinol       Date:  2015-04-05       Impact factor: 3.257

3.  Assessment of the luteal phase in stimulated and substituted cycles.

Authors:  H M Fatemi
Journal:  Facts Views Vis Obgyn       Date:  2009

4.  Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome.

Authors:  Dattaprasad B Inamdar; Abha Majumdar
Journal:  J Hum Reprod Sci       Date:  2012-09

5.  GnRH agonists to sustain the luteal phase in antagonist IVF cycles: a randomized prospective trial.

Authors:  Francesco M Fusi; Claudio M Brigante; Laura Zanga; Mario Mignini Renzini; Chiara Bosisio; Rubens Fadini
Journal:  Reprod Biol Endocrinol       Date:  2019-11-29       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.